Grimes & Company’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,754
| Closed | -$251K | – | 317 |
|
|
2021
Q3 | $251K | Buy |
5,754
+200
| +4% | +$8.72K | 0.01% | 260 |
|
|
2021
Q2 | $232K | Buy |
5,554
+538
| +11% | +$22.5K | 0.01% | 270 |
|
|
2021
Q1 | $243K | Buy |
5,016
+3,017
| +151% | +$146K | 0.01% | 251 |
|
|
2020
Q4 | $196K | Buy |
1,999
+234
| +13% | +$22.9K | 0.01% | 256 |
|
|
2020
Q3 | $122K | Buy |
1,765
+720
| +69% | +$49.8K | 0.01% | 240 |
|
|
2020
Q2 | $110K | Sell |
1,045
-220
| -17% | -$23.2K | 0.01% | 239 |
|
|
2020
Q1 | $112K | Hold |
1,265
| – | – | 0.01% | 216 |
|
|
2019
Q4 | $144K | Buy |
1,265
+250
| +25% | +$28.5K | 0.01% | 256 |
|
|
2019
Q3 | $63K | Buy |
+1,015
| New | +$63K | ﹤0.01% | 250 |
|